Luminate Medical are set to provide a device that could stop hair loss in chemotherapy patients.
The first pain-free, portable method to stop chemotherapy-induced hair loss is being developed by Luminate Medical and is called LILY.
The insecurities experienced by cancer patients who are experiencing hair loss served as inspiration for the idea. It is hoped that the device would eventually receive FDA approval in the US after being tested on healthy people in University Hospital Galway.
Lily will stop the negative side effects of chemotherapy in an area that is generally not impacted by cancer.
The compression cap’s mechanism of operation involves exerting pressure to the entire scalp’s surface. It stops chemotherapy from entering blood arteries close to hair follicles, halting the hair loss process. Currently, the primary technique of treatment for chemotherapy-related hair loss is scalp cooling, however this approach frequently results in severe pain.
Luminate Medical also wants to make the gadget as widely available as possible to the general public, with the goal of using it in public healthcare settings.
For further information on Luminate Medical and Lily, click here